Microwave ablation versus hepatic resection for the treatment of hepatocellular carcinoma and oesophageal variceal bleeding in cirrhotic patients

References

• Jemal A, Siegel R, Ward E, et al. (2009). Cancer statistics, 2009. CA Cancer J Clin 59:225–49.
   PubMed Web of Science ®Google Scholar
• Cheng AL, Kang YK, Chen Z, et al. (2009). Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 10:25–34.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Ricci S, Mazzaferro V, et al. (2008). Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378–90.
   PubMed Web of Science ®Google Scholar
• Stroffolini T, Andreone P, Andriulli A, et al. (1998). Characteristics of hepatocellular carcinoma in Italy. J Hepatol 29:944–52.
   PubMed Web of Science ®Google Scholar
• Benvegnu L, Gios M, Boccato S, Alberti A. (2004). Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut 53:744–9.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Bru C, Bruix J. (1999). Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329–38.
   PubMed Web of Science ®Google Scholar
• Giannini EG, Risso D, Testa R, et al. (2006). Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma. Clin Gastroenterol Hepatol 4:1378–84.
   PubMed Web of Science ®Google Scholar
• Ueno S, Tanabe G, Nuruki K, et al. (2002). Prognosis of hepatocellular carcinoma associated with child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center. J Hepatobiliary Pancreat Surg 9:469–77.
   PubMedGoogle Scholar
• Jensen DM. (2002). Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology 122:1620–30.
   PubMed Web of Science ®Google Scholar
• Bruix J, Castells A, Bosch J, et al. (1996). Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111:1018–22.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. (2011). Management of hepatocellular carcinoma: an update. Hepatology 53:1020–2.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. Practice Guidelines Committee AAftSoLD. (2005). Management of hepatocellular carcinoma. Hepatology 42:1208–36.
   PubMed Web of Science ®Google Scholar
• Capussotti L, Ferrero A, Vigano L, et al. (2006). Portal hypertension: contraindication to liver surgery? World J Surg 30:992–9.
   PubMed Web of Science ®Google Scholar
• Kawano Y, Sasaki A, Kai S, et al. (2008). Short- and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis. Ann Surg Oncol 15:1670–6.
   PubMed Web of Science ®Google Scholar
• Santambrogio R, Kluger MD, Costa M, et al. (2013). Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh's A cirrhosis: is clinical evidence of portal hypertension a contraindication? HPB (Oxford) 15:78–84.
   PubMed Web of Science ®Google Scholar
• Cucchetti A, Ercolani G, Vivarelli M, et al. (2009). Is portal hypertension a contraindication to hepatic resection? Ann Surg 250:922–8.
   PubMed Web of Science ®Google Scholar
• Capussotti L, Ferrero A, Vigano L, et al. (2009). Liver resection for HCC with cirrhosis: surgical perspectives out of EASL/AASLD guidelines. Eur J Surg Oncol 35:11–15.
   PubMed Web of Science ®Google Scholar
• Tandon P, Garcia-Tsao G. (2006). Portal hypertension and hepatocellular carcinoma: prognosis and beyond. Clin Gastroenterol Hepatol 4:1318–19.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Burroughs A, Bruix J. (2003). Hepatocellular carcinoma. Lancet 362:1907–17.
   PubMed Web of Science ®Google Scholar
• EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. (2012). J Hepatol 56:908–43.
   PubMed Web of Science ®Google Scholar
• Livraghi T, Solbiati L, Meloni MF, et al. (2003). Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226:441–51.
   PubMed Web of Science ®Google Scholar
• Dong B, Liang P, Yu X, et al. (2003). Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. AJR Am J Roentgenol 180:1547–55.
   PubMed Web of Science ®Google Scholar
• Facciorusso A, Di Maso M, Muscatiello N. (2016). Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperthermia32:339–44.
   PubMed Web of Science ®Google Scholar
• Liang P, Dong B, Yu X, et al. (2003). Prognostic factors for percutaneous microwave coagulation therapy of hepatic metastases. AJR Am J Roentgenol 181:1319–25.
   PubMed Web of Science ®Google Scholar
• Huang H, Liang P, Yu XL, et al. (2015). Safety assessment and therapeutic efficacy of percutaneous microwave ablation therapy combined with percutaneous ethanol injection for hepatocellular carcinoma adjacent to the gallbladder. Int J Hyperthermia 31:40–7.
   PubMed Web of Science ®Google Scholar
• Li M, Yu X, Liang P, et al. (2015). Ultrasound-guided percutaneous microwave ablation for hepatic malignancy adjacent to the gallbladder. Int J Hyperthermia 31:579–587.
   PubMed Web of Science ®Google Scholar
• Zhang D, Xie D, Wei X, et al. (2014). Microwave ablation of the liver abutting the stomach: insulating effect of a chitosan-based thermosensitive hydrogel. Int J Hyperthermia 30:126–33.
   PubMed Web of Science ®Google Scholar
• Yin L, Liu H, Zhang Y, Rong W. (2013). The surgical treatment for portal hypertension: a systematic review and meta-analysis. ISRN Gastroenterol 2013:464053. doi: 10.1155/2013/464053.
   PubMedGoogle Scholar
• Yang L, Yuan LJ, Dong R, et al. (2013). Two surgical procedures for esophagogastric variceal bleeding in patients with portal hypertension. World J Gastroenterol 19:9418–24.
   PubMed Web of Science ®Google Scholar
• Higashi H, Matsumata T, Utsunomiya T, et al. (1993). Successful treatment of early hepatocellular carcinoma and concomitant esophageal varices. World J Surg 17:398–402.
   PubMed Web of Science ®Google Scholar
• Harada A, Nonami T, Nakao A, et al. (1996). Surgical treatment for hepatocellular carcinoma and concomitant esophagogastric varices. Semin Surg Oncol 12:193–6.
   PubMedGoogle Scholar
• North Italian Endoscopic Club for the S, Treatment of Esophageal V. (1988). Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 319:983–9.
   PubMed Web of Science ®Google Scholar
• Wu YK, Wang YH, Tsai CH, et al. (2002). Modified Hassab procedure in the management of bleeding esophageal varices–a two-year experience. Hepatogastroenterology 49:205–7.
   PubMed Web of Science ®Google Scholar
• Ripoll C, Genesca J, Araujo IK, et al. (2013). Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case-control study. Hepatology 58:2079–88.
   PubMed Web of Science ®Google Scholar
• Chen WC, Lo GH, Lai KH, et al. (2004). Development of hepatocellular carcinoma after successful management of esophageal variceal bleeding. J Chin Med Assoc 67:557–64.
   PubMedGoogle Scholar
• Thuluvath PJ, Yoo HY. (2002). Portal hypertensive gastropathy. Am J Gastroenterol 97:2973–8.
   PubMed Web of Science ®Google Scholar
• Ohta M, Yamaguchi S, Gotoh N, Tomikawa M. (2002). Pathogenesis of portal hypertensive gastropathy: a clinical and experimental review. Surgery 131:S165–S70.
   PubMed Web of Science ®Google Scholar
• Ruzzenente A, Valdegamberi A, Campagnaro T, et al. (2011). Hepatocellular carcinoma in cirrhotic patients with portal hypertension: is liver resection always contraindicated? World J Gastroenterol 17:5083–8.
   PubMed Web of Science ®Google Scholar
• Choi GH, Park JY, Hwang HK, et al. (2011). Predictive factors for long-term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinoma. Liver Int 31:485–93.
   PubMed Web of Science ®Google Scholar
• Ishizawa T, Hasegawa K, Aoki T, et al. (2008). Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 134:1908–16.
   PubMed Web of Science ®Google Scholar
• Huang Q, Yang H, Lin QN, Qin X. (2016). 'Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis': two issues should be noted. Int J Hyperthermia 32:345. doi: 10.1080/02656736.2016.1257824.
   PubMed Web of Science ®Google Scholar
• Qian GJ, Wang N, Shen Q, et al. (2012). Efficacy of microwave versus radiofrequency ablation for treatment of small hepatocellular carcinoma: experimental and clinical studies. Eur Radiol 22:1983–90.
   PubMed Web of Science ®Google Scholar
• Wright AS, Sampson LA, Warner TF Jr, et al. (2005). Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology 236:132–9.
   PubMed Web of Science ®Google Scholar
• Kuang M, Lu MD, Xie XY, et al. (2007). Liver cancer: increased microwave delivery to ablation zone with cooled-shaft antenna-experimental and clinical studies. Radiology 242:914–24.
   PubMed Web of Science ®Google Scholar
• Pescatori LC, Sconfienza LM, Mauri G. (2016). The role of contrast-enhanced ultrasonography in image-guided liver ablations. Ultrasonography 35:87–8.
   PubMed Web of Science ®Google Scholar
• Mauri G, Porazzi E, Cova L, et al. (2014). Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment. Insights Imaging 5:209–16.
   PubMedGoogle Scholar
• Mauri G, Cova L, De Beni S, et al. (2015). Real-time US-CT/MRI image fusion for guidance of thermal ablation of liver tumors undetectable with US: results in 295 cases. Cardiovasc Intervent Radiol 38:143–51.
   PubMed Web of Science ®Google Scholar
• Mauri G. (2015). Expanding role of virtual navigation and fusion imaging in percutaneous biopsies and ablation. Abdomin Imaging 40:3238–9.
   PubMedGoogle Scholar